CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

MarketScreener Strategies Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Delayed Nyse Other stock markets 21:00:02 16/01/2026 GMT			5-day change	1st Jan Change
219.70 ^USD	-1.69%		-0.55%	+10.14%

01-16	Citigroup Adjusts Price Target on Charles River Laboratories International to $265 From $200, Maintains Buy Rating	MT
01-13	Charles River Laboratories International, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM

MarketScreener Strategies

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Rankings

Rankings

Currency / Forex

Currencies & Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area

Stock Market
Equities
CRL Stock
News Charles River Laboratories International, Inc.
MarketScreener Strategies

The best tools reserved for subscribers to boost the performance of your investments!